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Abstract: Predicting the outcome of in vitro fertilization (IVF)/
intracytoplasmic sperm injection (ICSI) is one main goal of the present
research on assisted reproduction. To understand whether density
gradient centrifugation (DGC), used to select sperm, can affect sperm
DNA integrity and impact pregnancy rate (PR), we prospectively
evaluated sperm DNA fragmentation (sDF) by TUNEL/PI, before
and after DGC. sDF was studied in a cohort of 90 infertile couples
the same day of IVF/ICSI treatment. After DGC, sDF increased in 41
samples (Group A, median sDF value: 29.25% [interquartile range,
IQR: 16.01–41.63] in pre- and 60.40% [IQR: 32.92–93.53] in post-
DGC) and decreased in 49 (Group B, median sDF value: 18.84% [IQR:
13.70–35.47] in pre- and 8.98% [IQR: 6.24–15.58] in post-DGC). PR
was 17.1% and 34.4% in Group A and B, respectively (odds ratio [OR]:
2.58, 95% confidence interval [CI]: 0.95–7.04, P¼ 0.056). After
adjustment for female factor, female and male age and female BMI,
the estimated OR increased to 3.12 (95% CI: 1.05–9.27, P¼ 0.041).
According to the subgroup analysis for presence/absence of female
factor, heterogeneity in the association between the Group A and B and
PR emerged (OR: 4.22, 95% CI: 1.16–15.30 and OR: 1.53, 95% CI:
0.23–10.40, respectively, for couples without, n¼ 59, and with, n¼ 31,arco Nadalini, Ph iani, PhD,
, MD, Elisabetta Baldi, PhD, and Andrea Borini, MD
IVF/ICSI, who then show a much lower probability of pregnancy,
raising concerns about the safety of this selection procedure. Evaluation
of sDF before and after DGC configures as a possible new prognostic
parameter of pregnancy outcome in IVF/ICSI. Alternative sperm selec-
tion strategies are recommended for those subjects who undergo the
damage after DGC.
(Medicine 95(20):e3624)
Abbreviations: ARTs = assisted reproductive techniques, BMI =
body mass index, DGC = density gradient centrifugation, ICSI =
intracytoplasmic sperm injection, IQR = interquartile range, IVF =
in vitro fertilization, OR = odd ratio, PI = propidium iodide, PR =
pregnancy rate, sDF = sperm DNA fragmentation, TdT = terminal
deoxynucleotidyl transferase.
INTRODUCTION
I n developed countries 1.7% to 4% of births derive from theapplication of assisted reproductive techniques (ARTs),1
which represent the main medical treatment for most infertile
couples. Despite ARTs success having improved greatly in the
last decades, the current pregnancy rate (PR) in European
countries remains low (about 30%).2
Many factors are believed to influence the in vitro ferti-
lization/intracytoplasmic sperm injection (IVF/ICSI) outcome,
including the fact that a clinical laboratory setting cannot
recreate the conditions of natural conception. In particular,
whereas in natural conditions selection of the male gametes
occurs during transit in the female genital tracts, in the ART
laboratory, spermatozoa are selected with routine separation
techniques such as density gradient centrifugation (DGC). The
latter procedure selects spermatozoa with better morphology,
motility,3 and chromatin maturity4 and blunts the amount of
immature germ cells and leukocytes,5 considered responsible
for high levels of oxidative stress in semen.6,7 However, proper
sperm selection is not sufficient to guarantee successful ferti-
lization, embryo development, establishment of pregnancy, and
delivery of live babies.8,9 The integrity of sperm chromatin is a
mandatory trait, especially in the case of aged women whose
oocytes may have a limited ability to repair the DNA damage
brought by the spermatozoon.10,11
Among the different types of DNA damage, sperm DNA
fragmentation (sDF) has been extensively investigated and
many studies have demonstrated its negative impact on ARTe health of offspring in animal models.17
s or decreases sDF is currently unclear.
ral studies have indicated that DGC
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morphology and then transferred into the uterus.12 Clinicalimproves the yield of DNA-intact spermatozoa,18 others have
reported no change or even a worsening of DNA quality in
DGC-selected spermatozoa.19–23 In addition, and most impor-
tantly, whether an eventual effect of DGC procedure on DNA
damage impacts pregnancy achievement by ART is
presently unknown.
We report here the effect of DGC on sDF levels, as
assessed in the same samples utilized for IVF/ICSI treatments
and the impact of such an effect on PR after ART.
MATERIAL AND METHODS
Patients
Infertile couples undergoing ART cycles were prospec-
tively recruited at Tecnobios Procreazione (Bologna and Udine,
Italy) from January 2012 to December 2014. Of the 103
recruited couples, 13 were excluded from the study because
embryos were frozen and embryo transfer postponed (n¼ 10) or
because it was not possible to determine sDF in both unselected
and DGC selected sperm (n¼ 3). In the remaining 90 couples
(79 treated by IVF and 11 by ICSI), the infertility diagnosis was:
49% female factor (including diminished ovarian reserve, uter-
ine factors, endometriosis and tubal factors), 8% male factor,
9% male and female factor in combination, and 35% unex-
plained. As in ARTs the tubal factor is completely overcome by
embryo transfer, this diagnosis (n¼ 20) was not considered as a
female factor in the statistical analyses. The obtainment of an
informed written consent was the only criterion for inclusion in
the study. The study initially planned to evaluate the impact of
sDF levels in pre- and post-DGC semen samples on PR after
IVF/ICSI treatment of infertile couples and was approved as
such by the ethical committee of Azienda Ospedaliera Uni-
versitaria Careggi (protocol no. 54/10). The different effect of
DGC on sDF levels and the impact of the increase/decrease of
sDF during DGC on PR were observed and further investigated
during data analysis. Clinical data, standard semen parameters,
and flow cytometric measures of sDF were centralized in an
electronic database at the Unit of Sexual Medicine and Androl-
ogy of the University of Florence.
Sperm Collection and Preparation
Semen samples were collected by masturbation and ana-
lyzed for sperm number, concentration, motility, and
morphology according to WHO procedures.24 Sperm selection
for IVF/ICSI treatment was performed by discontinuous Pure-
Sperm (Nidacon, Gothemberg, Sweden) gradient.12 Briefly,
semen samples were layered upon a 40:80% PureSperm density
gradient, processed by centrifugation at 600g for 15 minutes and
resuspended in 1 mL of sperm culture medium (PureSperm
wash, Nidacon, Gothemberg, Sweden). After DGC, evaluation
of concentration, total and progressive motility and morphology
was repeated. All semen analyses were conducted on the same
day of IVF procedure before evaluation of sDF.
Ovarian Stimulation, IVF, ICSI, and Embryo
Development
Ovarian stimulation was achieved by recombinant follicle-
stimulating hormone (Gonal F, Serono, Rome, Italy; Puregon,
Organon, Rome, Italy) and monitored by endovaginal echo-
graphy and plasma estradiol evaluation.12 Thirty-six hours
Muratori et albefore oocyte retrieval, 10,000 IU of hCG (Gonasi, Amsa,
Rome, Italy) was administered.12 Oocyte retrieval was carried
out under general anesthesia by a vaginal ultrasonography-
2 | www.md-journal.comguided aspiration.12 At 16 to 18 hours after insemination or
microinjection, as previously described,25,26 oocytes were
assessed for 2 pro-nuclei presence. Forty-eight hours after
oocyte retrieval, embryos were classified according to their
Medicine  Volume 95, Number 20, May 2016pregnancy was determined by ultrasound detection of gesta-
tional sac.12
TUNEL/PI Coupled to Flow Cytometry
sDF was determined in spermatozoa before and after DGC
on the day of oocytes retrieval. After washing twice with Sperm
Wash Medium, semen samples (3–10 106 sperm) were fixed
with 200mL of paraformaldehyde (4% in phosphate-buffered
saline [PBS], pH 7.4) for 30 minutes at room temperature. For
labeling DNA breaks, the In Situ Cell Death Detection Kit,
fluorescein, (Roche Molecular Biochemicals, Milan, Italy) was
used, as previously described.27 Briefly, semen samples were
washed twice with 200mL of PBS/1% bovine serum albumin,
and spermatozoa were permeabilized with 100mL of 0.1%
sodium citrate/0.1% Triton X-100 (4 minutes in ice), and
labeled with 50mL of labeling solution (supplied by the kit)
containing the terminal deoxynucleotidyl transferase (TdT)
enzyme (1 hour at 378C in the dark). Samples were then washed
twice, resuspended in 500mL of PBS and shipped at 48C27 to the
Unit of Sexual Medicine and Andrology of the University of
Florence. For detection of sDF, samples were stained with PI
(0.6mg/mL, 10 minutes at room temperature in the dark) and
acquired using a flow cytometer FACScan (Becton Dickinson,
Mountain View, CA) equipped with a 15-mW argon-ion laser
for excitation. For each test sample, 3 further sperm suspensions
were prepared for instrumental setting, fluorescence compen-
sation, and data analysis: by omitting both PI staining and TdT;
by omitting only TdT (negative control); and by omitting only
PI staining. Green fluorescence of TUNEL labeling was
revealed by an FL-1 detector (515–555 nm wavelength band)
and red fluorescence of PI was detected by an FL-2 detector
(563–607 nm wavelength band). For each sample, 8000 events
were recorded within the flame-shaped region (FR) character-
istic of spermatozoa27 in the forward light scatter/side light
scatter dot plot. This region excludes debris and large cells (such
as somatic ones) and includes spermatozoa and semen apoptotic
bodies.28,29 The latter can be excluded from the analysis of sDF
subsequently, by gating the nucleated events (ie, the events
labeled with PI) within FR.27This strategy guarantees that
TUNEL fluorescence is analyzed in a population formed by
only and all spermatozoa present in the analyzed semen
sample.28–30 As shown in Figure 1 A and B, reporting pre-
and post-DGC TUNEL/PI dot plots in representative samples of
Groups A and B (see below), respectively, for determination of
the percentages of sDF, a vertical marker is established in the
TUNEL axis of the dot plot of negative control, including 99%
of events. Such a marker is translated in the corresponding test
sample and all the events beyond the marker are considered as
TUNEL positive. TUNEL/PI detects sDF in the total and in 2
different sperm populations, brighter and dimmer.28 Dimmer
sperm (Figure 1 A, B in blue) are all dead (besides DNA
fragmented)31,32 and thus they are almost completely blunted
during DGC (Figure 1A, B), provoking per se a decrease of sDF
in postselection samples. This decrease owing to the blunting of
dead dimmer sperm can mask the eventual increase in brighter
ones if sDF is evaluated in the total sperm population. Con-
versely, evaluation of the variation of sDF during DGC in the
brighter population (Figure 1A, B in red) is more sensitive in
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
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FIGURE 1. Typical PI/TUNEL dot plots of pre- and post-DGC samples in subjects wherein selection induces an increase (A) or a decrease (B)
of spermDNA fragmentation (sDF). Note the presence on y axis of 2 spermpopulations, differing for the intensity of PI staining (brighter in
blue and dimmer in red) and that the dimmer one is virtually blunt in post-DGC samples. Measures of sDF before and after DGC refers to
the brighter population (see also Material and Methods section). Negative control, samples prepared by omitting TdT enzyme. (C) Pre-
and post-DGC sDF levels in the 90 subjects included in the study. DGC¼density gradient centrifugation.
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detecting eventual increases of sDF. Hence, to investigate the
effect of selection on sperm DNA damage, we calculated sDF
before and after DGC in only the brighter population (hereafter
termed sDF).
Statistical Analysis
The study was designed to explore the impact of sDF levels
in pre- and post-DGC semen samples on PR, without any
prespecified hypothesis; the number of required couples was
not calculated. All continuous variables were assessed for
normal distribution with the Kolmogorov-Smirnov test and
results were expressed as median (IQR) or as both median
(IQR) and mean (SD). Female body mass index (BMI) was
analyzed as a continuous variable after single imputation of
missing values in 13 cases. The Mann–Whitney U test was used
for comparing sDF in pregnant and nonpregnant couples. In
some cases, a multifactor analysis of variance was also used.
Comparisons of proportions were performed with the x2 test for
heterogeneity. The variation of the parameters evaluated before
and after DGC was tested by means of the Wilcoxon signed
ranks test.
sDF was considered increased (Group A) or decreased
(Group B) after DGC when the coefficient of variation (CV)
between pre- and post-DGC measures was >5% (intra-assay
CV of the TUNEL/PI technique).27 Samples showing CVs<5%
(n¼ 4) were considered as increased. Belonging to Group A or
B is hereafter termed A/B variable (categorical variable).
To assess the ability of total sperm number and concen-
Muratori et altration to predict the outcome of DGC, receiver-operating
characteristic (ROC) curves were built and the area under
the curve (AUC) calculated.
TABLE 1. Male and Female Age, Presence of Female and Male F
Group A and B
Variable
Total
(n¼ 90)
Female age 34.77 3.17
35.00 (33.00–37.00)
Female factor 31/90 (34.4%)
Female BMI 21.65 4.07
20.80 (19.13–23.00)
Male age 37.37 4.22
37.00 (35.00–40.00)
Male factor 14/90 (15.5%)
Male abstinence, days 3.74 2.37
3.00 (3.00–4.00)
Sperm concentration, millions/mL 46.91 32.01
40.00 (23.00–65.75)
Sperm Number (millions/ejaculate) 103.23 86.28
86.35 (60.00–23.30) 6
Total Motility (%) 43.72 8.60
40.00 (40.00–50.00)
Progressive Motility (%) 37.21 8.11
35.00 (34.75–41.25)
Normal Morphology (%) 25.03 6.68
28.00 (20.00–28.00)
Data are represented as meanSD and median (IQR). BMI¼ body mas
Group A vs B; Mann–Whitney U test.
yGroup A vs B; x2 test for heterogeneity.
4 | www.md-journal.comThe association between the clinical parameters, including
the A/B variable and PR (number of clinical pregnancies/
number of treated couples), was studied in a binary logistic
model, both in univariate and multivariate settings. Subgroup
analyses were performed by means of an interaction test to
determine the consistency of the association between A/B
variable and PR according to key baseline characteristics.
The likelihood ratio test was used to test the linear hypotheses
about the regression coefficients.
All statistical tests were 2-sided, and P values of 0.05
were considered to indicate statistical significance. Data were
analyzed with SAS Statistical Software, version 9.2 (SAS
Institute Inc, Cary, NC).
RESULTS
Age of male and female partners, pre- and post-DGC
sperm parameters, and sDF levels of the subjects included in
the study are reported in Tables 1 and 2. As shown, median
values of sDF were not affected by selection (Table 2); how-
ever, when individual samples were considered, we found that
in 41 of 90 (46%) of them (Group A), sDF increased, even
dramatically in some cases (Figure 1C). In the remaining 49 of
90 (54%) samples (Group B), sDF, after selection, decreased
(Figure 1C). The 2 groups of subjects differed in pre-DGC total
sperm number and concentration (Table 1) and post-DGC sDF
values (Table 2). Of note, DGC selection resulted in the
expected increase in sperm motility, in both groups
(Table 2). Considering that pre-DGC sperm number and con-
Medicine  Volume 95, Number 20, May 2016centration differ between the 2 groups (Table 1), we evaluated
whether the 2 parameters were able to predict the outcome of
DGC by ROC curve analysis. Both parameters predicted DGC
actor and Semen Parameters in All Recruited Subjects and in
Group A Group B
P(n¼ 41) (n¼ 49)
34.54 3.34 34.96 3.00 0.825
32.50 (35.00–37.50) 35.00 (33.00–37.00)
13/41 (31.7%) 18/49 (36.7%) 0.617y
21.33 3.31 21.91 4.63 0.4316
20.50 (19.00–22.20) 21.10 (19.70–23.00)
36.73 4.30 37.90 4.11 0.135
36.50 (34.00–39.75) 38.00 (36.00–40.50)
6/41 (14.6%) 8/49 (16.3%) 0.825y
3.95 2.34 3.57 2.40 0.1968
3.000 (3.00–4.00) 3.00 (3.00–3.00)
39.24 29.85 53.32 32.64 0.010
31.00 (20.00–60.00) 42.00 (32.50–71.50)
83.63 50.68 119.63 105.16 0.016
7.20 (43.70–117.90) 100.00 (71.75–131.00)
43.41 8.325 43.98 8.90 0.913
40.00 (40.00–50.00) 40.00 (40.00–50.00)
37.44 8.597 37.02 7.77 0.703
35.00 (30.00–45.00) 35.00 (35.00–40.00)
24.59 8.11 25.41 5.26 0.671
28.00 (20.00–28.00) 28.00 (20.00–28.00)
s index.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 2. Pre and Post-DGC Values of Total and Progressive Motility, and of sDF in Total Recruited Subjects and in Group A and B
Variable Total (n¼ 90) Group A (n¼ 41) Group B (n¼ 49) P
Total motility (%)
Pre-DGC 43.72 8.597 43.41 8.325 43.98 8.896 0.913
40 (40.00–50.00) 40 (40.00–50.00) 40 (40.00–50.00)
Post-DGC 89.67 4.23 89.39 4.90 89.90 3.61 0.975
90 (90.00–90.00) 90 (90.00–90.00) 90 (85.00–92.50)
Py <0.001 <0.001 <0.001
Progressive motility (%)
Pre-DGC 37.21 8.115 37.44 8.60 37.02 7.77 0.703
35 (34.75–41.25) 35 (30.00–45.00) 35 (35.00–40.00)
Post-DGC 84.00 5.31 83.54 6.91 84.39 3.48 0.814
85 (80.00–85.00) 85 (82.50–85.00) 85 (80.00–85.00)
Py <0.001 <0.001 <0.001
sDF (%)
Pre-DGC 29.20 17.70 31.21 16.27 27.53 18.82 0.162
24.45 (15.37–39.54) 29.25 (16.01–41.63) 18.84 (13.70–35.47)
Post-DGC 33.06 31.43 58.06 29.71 12.39 11.03 <0.001
17.87 (8.17–53.00) 54.6 (31.58–91.25) 8.98 (6.24–15.58)
Py 0.746 <0.001 <0.001
Data are represented as meanSD and median (IQR). DGC¼ density gradient centrifugation, sDF¼ sperm DNA fragmentation.
Group A vs B; Mann–Whitney U test.
yPre- vs post-DGC; Wilcoxon signed ranks test.
Medicine  Volume 95, Number 20, May 2016 Density Gradient Centrifugation and IVF/ICSI Pregnancy Rateoutcome with AUC values of 0.657 (95% confidence interval
[CI]: 0.543–0.771, P¼ 0.010) and 0.648 (95% CI: 0.531–
0.766, P¼ 0.016), respectively, for sperm concentration and
number. Male as well as female factor was similarly distributed
in the 2 groups (Table 1).
Table 3 reports PR in the 2 groups. As shown, PR was
34.7% in group B and 17.1% in group A (odds ratio
[OR]¼ 2.58, 95% CI: 0.95–7.04; P¼ 0.056) (Figure 2).
Table 3 also reports the results of univariate analysis of the
association between A/B variable, presence of female factor,
female age, male age, and female BMI and PR. As can be
observed, women’s age represents another factor approaching
statistical significance in affecting PR; in particular, for every
year of aging, the chance of pregnancy decreases by 13%.
TABLE 3. Univariate Analysis of the Association Between Evaluat
Variable No. of Couples (N¼ 90) No. of Pre
Group
Subjects A 41 7
Subjects B 49 17
Female factor
Absent 59 18
Present 31 6
Female age, y (cont.) —
Male age, y (cont.) —
BMI —
BMI¼ body mass index, CI¼ confidence interval, OR¼ odds ratio.
x2 test for heterogeneity.
yLikelihood ratio test.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.Consistently, the PR was 35% and 18% in women with an age,
respectively,<35 and35 years (median value of the cohort of
this study). Standard semen parameters as well as the presence
of male factor did not differ between couples achieving or not
pregnancy (data not shown).
After adjustment for the presence of female factor, female
age, male age, and female BMI, the probability of achieving
pregnancy for Group B further increased with an OR value of
3.12 (95% CI: 1.05–9.27, P¼ 0.041) (Table 4). Another
possible confounder is basal sperm concentration, which differs
between Groups A and B (Table 1). However, this parameter
does not impact PR (OR¼ 1.00; 95% CI: 0.99–1.01, P¼ 0.480)
and thus cannot be considered a confounding factor in this study
population. Consistently, if sperm concentration is added as a
ed Clinical Parameters and Pregnancy Rate
gnancies (N¼ 34) P OR (95% CI) Py
(17.1%) 0.060 1 (ref.) 0.056
(34.7%) 2.58 (0.95–7.04)
(30.5%) 0.256 1 (ref.) 0.247
(19.4%) 0.55 (0.19–1.56)
— — 0.87 (0.74–1.01) 0.056
— — 0.95 (0.85–1.06) 0.365
— — 1.07 (0.96–1.19) 0.243
www.md-journal.com | 5
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All couples, n=90 
Couples with female age <35, n=42 
Couples with female factor, n=31 
Couples without female factor,  n=59 
Couples with female age ≥35, n=48 
All couples (adj for female factor, female and male age and 
 female BMI), n=90 
niva
Muratori et al Medicine  Volume 95, Number 20, May 2016confounder in the multivariate analysis, no substantial change in
OR for pregnancy in Group B is observed (not shown). Since no
pregnancy was obtained in the 11 couples treated with ICSI (vs
FIGURE 2. Forest plot of ORs in Group B in the total cohort in u
analysis. OR¼odd ratios.30.4% in IVF), we evaluated the distribution of the type of
treatment in the 2 groups. ICSI and IVF were equally distributed
in Group A (6/49, 12.24%) and B (5/41, 12.20%), P¼ 0.998.
TABLE 4. Multivariate Analysis of the Association Between
Evaluated Clinical Parameters and Incidence of Pregnancy
(N¼90)
Variable OR (95% CI) P

Group
Subjects A 1 (ref.) 0.041
Subjects B 3.12 (1.05–9.27)
Female factor
Absent 1 (ref.) 0.198
Present 0.48 (0.15–1.48)
Female age, y (cont.) 0.84 (0.70–1.01) 0.067
Male age, y (cont.) 0.99 (0.86–1.13) 0.864
BMI 1.08 (0.96–1.21) 0.226
BMI¼ body mass index, CI¼ confidence interval, OR¼ odds ratio.
Likelihood ratio test.
6 | www.md-journal.comTo further verify whether the association between the A/B
variable and PR was affected by the presence of a female factor,
a subgroup analysis was performed. We found that in the 59
couples without female factor, PR was 41.9% in Group B as
compared to 17.8% in Group A (OR¼ 4.22, 95% CI: 1.16–
15.3, Figure 2). Conversely, within the 31 couples with a female
factor, PR in Group B was 22.0% with respect to 15.4% in
Group A (OR¼ 1.53, 95% CI: 0.23–10.4; test for interaction
P¼ 0.396; Figure 2).
Finally, no significant interaction between the A/B vari-
able and female age (<35 vs35 years) was present (Figure 2).
Indeed, in the 42 women younger than 35 years, PR was 25%
and 45%, respectively, in Groups A and B, whereas in the 48
women aged 35 years or older, PR was 9% and 26%, respect-
ively, in Groups A and B, indicating that the relative probability
to achieve pregnancy in Group A versus B was not affected by
female age (Figure 2).
Pre- and post-DGC sDF values were not different
between couples achieving or not achieving pregnancy
(26.75% [12.76%–40.63%] vs 24.34% [15.37%–39.54%],
P¼ 0.920 in pre- and 11.48% [6.45%–60.13%] vs 26.21%
[9.18%–56.48%], P¼ 0.177 in post-DGC samples). After
adjusting for the presence of female factor and male and
female age in a multivariate model, the difference of post-
riate, after adjustment for confounding factors and in subgroupDGC sDF levels between couples achieving or not achieving
pregnancy approached the statistical significance level
(P¼ 0.071).
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
DISCUSSION
Predicting successful pregnancy in IVF/ICSI is one of the
goals of present research in the field of assisted reproduction.
This study shows, for the first time, that DGC selection of sperm
for ARTs may induce sDF and, most importantly, when such an
event occurs, the couples have about a 50% lower chance to
achieve pregnancy. As such, the variation of sDF after DGC (A/
B variable) configures as a new predictive parameter of preg-
nancy outcome in ARTs.
Our study demonstrates that DGC selection is not devoid
of risk for sperm DNA integrity. Indeed, we found that besides
the subjects in which DGC selection produces a decrease in
sDF, mainly owing to deletion of mostly DNA fragmented
moribund/dead cells,33 in about 50% of subjects, post-DGC
sDF levels are higher as compared to pre-DGC values,
suggesting the induction of a de novo DNA damage during
the procedure. The causes of this damage are unclear. Although
initial studies suggested that the shearing forces generated
during centrifugation can damage sperm DNA through gener-
ation of reactive oxygen species,21,34 recent data demonstrated
that contamination of commercially available colloidal silicon
gradients by transition metals is the main cause of oxidative
damage and breakage to sperm DNA during DGC.22 However,
the fact that not all the samples undergo an increase of sDF
during selection indicates that metal contamination of gradi-
ents is not sufficient to induce the damage. We hypothesize that
the concomitant presence of intrinsic features of chromatin
(such as defects in sperm chromatin maturation) or of other
sperm abnormalities (such as lower sperm defenses to oxi-
dative attack or high levels of ROS in semen) render the sample
more susceptible to the noxious agents. Whatever is the nature
of such abnormalities, it does not appear to be associated with
the presence of male factor infertility, which, in our study, was
equally distributed among the subjects of Groups A and B.
Moreover, although sperm concentration and number, among
pre-DGC parameters, were different between the 2 groups of
patients, ROC analysis demonstrated that they are poorly
predictive of the DGC outcome. Thus, at present, only evalu-
ation of pre- and post-DGC sDF can assign patients to one of
the 2 groups. Such evaluation should be performed determining
sDF with a method, such as the TUNEL/PI used in our study,
that excludes non-sperm elements that may be present in
variable amounts in selected and unselected samples.28,30 Only
in this case, a direct comparison of sDF levels between pre- and
post-DGC samples is possible. As mentioned before, subjects
whose semen samples underwent DNA damage during DGC
selection had a lower probability of achieving pregnancy. The
strength of this association further increases after adjustment
for potential confounding factors such as female factor infer-
tility, female age35 (and present study), female BMI,36–37 and
male age,38 which may also affect ART outcomes. Among such
confounders, female factor appears to be an effect modifier of
the association between the A/B variable and PR. In fact, the
subgroup analysis showed that in couples without female
factor, the OR for pregnancy of group B is similar to the
adjusted one. Conversely, despite the fact that the probability
for pregnancy in aged women was lower in both Groups A and
B, the relative probability of pregnancy of Group B with
respect to A is similar in women with an age <35 and
>35 years.
Medicine  Volume 95, Number 20, May 2016Many studies reported the impact of sDF on natural and
assisted reproduction showing a link to several fertility check
points (from fertilization to embryo quality and PR). The
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.presence of breaks in the male genome may be repaired by
the oocyte,10 but the ability of the oocyte to repair the damage
depends on several factors, including its quality, age of the
woman, and iatrogenic factors. It is also possible that the oocyte
repair machinery is not sufficient to repair all the DNA damage
present in the male genome or that mutations and epimutations
may be introduced because of partial oocyte repair11; in such
cases, the embryo may fail to develop or implant in the uterus or
may be miscarried at a later stage. In our cohort, pre-DGC sDF
values are not different between couples achieving or not
achieving pregnancy, whereas the difference in post-DGC
sDF levels is more evident, approaching significance after
adjustment for the presence of female factor and male and
female age. It is conceivable that statistical significance will be
reached with an enlarged number of couples. Finding that post-
DGC sDF levels better discriminate between couples achieving
or not achieving pregnancy than pre-DGC ones was expected
considering that DGC-selected sperm are those used for IVF/
ICSI procedures. However, in previous studies comparing pre-
and post-selection sDF levels, sDF in selected sperm did not
discriminate39 or discriminated less40–41 between pregnant and
nonpregnant couples compared to native semen. In the study by
Bungum et al,39 sperm chromatin structure assay was used to
reveal sDF. Interestingly, this method appears to be unable to
detect the DNA breakage induced by DGC selection,22 provid-
ing a possible explanation for the lack of impact of selected sDF
values on pregnancy after ART.37
Our study should be considered as preliminary owing to
the post-hoc nature of some analyses and, in some circum-
stances, to the low power level of the statistical tests. Whereas
the results on the effect of DGC on sDF levels are solid
(performed in 90 samples), it is necessary to confirm the impact
of the A/B variable on PR in an enlarged number of recruited
couples to consolidate it as a new predictive parameter for
ARTs outcome. Another limitation of the study is the lack of
data on male BMI. Although recent meta-analyses42,43 could
not univocally demonstrate the impact of this parameter on
ART outcome, some studies44,45 have reported that BMI may
affect clinical pregnancy and live birth rate.
In conclusion, our study demonstrates that DGC selection
of sperm for ART may be dangerous for DNA integrity in
approximately 50% of subjects, who then show a much lower
probability of pregnancy. This finding indicates that current
gradient preparation procedures to select sperm for ARTs may
negatively impact PR, evidencing the need to utilize alternative
strategies for sperm selection for those subjects in which DGC
produces the damage. Finally, our results show that the A/B
variable after DGC is a promising predictor of PR in ARTs,
independently of age and female factor. If, as expected, future
studies show that the A/B variable is a stable condition over
time in one individual, this semen trait could be useful for
counseling in the couple infertility workup.
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